We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M Turnover 22.64%
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
-1.82%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$1.11B
AUM Growth
-$55.5M
Cap. Flow
-$30.5M
Cap. Flow %
-2.75%
Top 10 Hldgs %
75.65%
Holding
63
New
–
Increased
1
Reduced
5
Closed
1
Avg Time Held
6.2 years
Top 10 Avg Time Held
4.6 years
Top 20 Avg Time Held
4.8 years

Top Buys

Rank Stock Value
1
VEEV icon
Veeva Systems
VEEV
+$145K

Top Sells

Rank Stock Value
1
ALPN icon
Alpine Immune Sciences Inc
ALPN
+$493K
2
MMM icon
3M
MMM
+$359K
3
CI icon
Cigna
CI
+$148K
4
FTV icon
Fortive
FTV
+$69.4K

Sector Composition

Rank Sector Weight
1 Financials 52.49%
2 Healthcare 17.62%
3 Materials 8.07%
4 Energy 7.76%
5 Technology 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MET icon
51
MetLife
MET
$64.4B
$743K 0.07%
10,580
– –
2020 Q4
14 quarters
IEX icon
52
IDEX
IEX
$17.2B
$545K 0.05%
2,710
– –
2022 Q1
9 quarters
VEEV icon
53
Veeva Systems
VEEV
$50B
$500K 0.05%
2,730
+730
+37% +$145K
2020 Q1
17 quarters
BN icon
54
Brookfield
BN
$81.4B
$415K 0.04%
15,000
– –
2023 Q1
5 quarters
AVXL icon
55
Anavex Life Sciences
AVXL
$123M
$361K 0.03%
85,585
– –
2018 Q4
22 quarters
VYM icon
56
Vanguard High Dividend Yield ETF
VYM
$81.4B
$288K 0.03%
2,430
– –
2022 Q1
9 quarters
USB icon
57
US Bancorp
USB
$91.2B
$210K 0.02%
5,300
– –
2016 Q2
32 quarters
OCUL icon
58
Ocular Therapeutix
OCUL
$1.53B
$116K 0.01%
17,000
– –
2021 Q4
10 quarters
CRVS icon
59
Corvus Pharmaceuticals
CRVS
$808M
$91K 0.01%
49,959
– –
2018 Q3
23 quarters
ALDX icon
60
Aldeyra Therapeutics
ALDX
$40.4M
$66K 0.01%
20,020
– –
2017 Q1
29 quarters
ALPN icon
61
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-12,445
Closed -$493K –
1 2
3

Similar funds

TPW
Talon Private Wealth The Villages, Florida $855M AUM
EWA
Evolution Wealth Advisors Aventura, Florida $855M AUM 27.24% 1-Year Est. Return
DCM
Dimension Capital Management Coral Gables, Florida $854M AUM 21.01% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $853M AUM 15.61% 1-Year Est. Return
QIM
Quest Investment Management Lake Oswego, Oregon $856M AUM 29.41% 1-Year Est. Return
AIMC
Alley Investment Management Company Lake Forest, Illinois $856M AUM 15.11% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $853M AUM 18.22% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return

Hikari Power's Q2 2024 Portfolio in Review

As of Q2 2024, Hikari Power held 63 positions worth $1.11B, down 4.8% from $1.16B the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 1.6%. Hikari Power opened no new positions and exited 1, leaving the 63-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 52% of assets, up from 52% a quarter earlier, followed by Healthcare and Materials.

  • Hikari Power added most to Veeva Systems in Q2 2024, an estimated $145K increase.
  • Hikari Power's biggest Q2 2024 reduction was 3M, cutting an estimated $359K.
  • Hikari Power fully exited Alpine Immune Sciences Inc in Q2 2024, selling an estimated $493K.
  • Hikari Power's ten largest holdings make up 76% of its $1.11B portfolio in Q2 2024.
  • Hikari Power opened 0 new positions and closed 1 in Q2 2024.
  • Hikari Power's portfolio value fell 4.8% quarter-over-quarter to $1.11B.

Based on Hikari Power's 13F filing for Q2 2024, filed 23 Jul 2024.